Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program
AUTOR(ES)
Francis, Glenn D
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2095464Documentos Relacionados
- External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme
- Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false‐positive or false‐negative immunohistochemistry?
- Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma.
- Ki-67, oestrogen receptor, and progesterone receptor proteins in the human rete ovarii and in endometriosis.
- Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer.